Search research articles
Contact Us
Filters
Showing results (381-390 of 551) with videos related to
Page
of 56
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1995
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions
B C Vrouenraets, J M Klaase, B B Kroon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group
S Aamdal, I Wolff, S Kaplan, et al.
Plos One
|
August 5, 2014
The effects of chronic cigarette smoking on gray matter volume: influence of sex
Teresa R Franklin, Reagan R Wetherill, Kanchana Jagannathan, et al.
Addiction Biology
|
October 16, 2012
Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene
Reagan R Wetherill, Kanchana Jagannathan, Falk W Lohoff, et al.
Journal of Clinical Epidemiology
|
November 30, 2024
Development of a refined harmonization approach for longitudinal cognitive data in people with HIV
Lang Lang, Leah H Rubin, Raha M Dastgheyb, et al.
Melanoma Research
|
March 1, 1994
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?
J M Klaase, B B Kroon, A N van Geel, et al.
Melanoma Research
|
December 1, 1992
The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes: a comparison between an iliac and femoral perfusion procedure
J M Klaase, B B Kroon, A N van Geel, et al.
Journal of Vascular Surgery
|
December 31, 1997
Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement
L A Killewich, R F Macko, K Cox, et al.
British Journal of Cancer
|
August 1, 1994
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
T Cerny, S Kaplan, N Pavlidis, et al.
The American Journal of Medicine
|
August 1, 1984
Safety and efficacy of continuous intravenous morphine for severe cancer pain
M L Citron, A Johnston-Early, B E Fossieck, et al.
Page
of 56
Search research articles
Search
Showing results (381-390 of 551) with videos related to
Sort By:
Page
of 56
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1995
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions
B C Vrouenraets, J M Klaase, B B Kroon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group
S Aamdal, I Wolff, S Kaplan, et al.
Plos One
|
August 5, 2014
The effects of chronic cigarette smoking on gray matter volume: influence of sex
Teresa R Franklin, Reagan R Wetherill, Kanchana Jagannathan, et al.
Addiction Biology
|
October 16, 2012
Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene
Reagan R Wetherill, Kanchana Jagannathan, Falk W Lohoff, et al.
Journal of Clinical Epidemiology
|
November 30, 2024
Development of a refined harmonization approach for longitudinal cognitive data in people with HIV
Lang Lang, Leah H Rubin, Raha M Dastgheyb, et al.
Melanoma Research
|
March 1, 1994
Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?
J M Klaase, B B Kroon, A N van Geel, et al.
Melanoma Research
|
December 1, 1992
The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes: a comparison between an iliac and femoral perfusion procedure
J M Klaase, B B Kroon, A N van Geel, et al.
Journal of Vascular Surgery
|
December 31, 1997
Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement
L A Killewich, R F Macko, K Cox, et al.
British Journal of Cancer
|
August 1, 1994
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
T Cerny, S Kaplan, N Pavlidis, et al.
The American Journal of Medicine
|
August 1, 1984
Safety and efficacy of continuous intravenous morphine for severe cancer pain
M L Citron, A Johnston-Early, B E Fossieck, et al.
Page
of 56